Private company · employee equity guide

BLogo by Brandfetch

What is BigHat Biosciences stock worth?

BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Qua

Estimated share price

Members onlySee the real chart, freeNo card. Takes about a minute. Preview blurred & illustrative.

BigHat Biosciences has an observed estimated price: most recent data 2026-07-29, daily history back to 2024-06-18.

Estimated from observed bids, offers, and closed transactions on a leading secondary marketplace. Private shares are illiquid and transfer-restricted; estimates are educational, not an offer or advice. How this is calculated

About BigHat Biosciences

Employees
98
Founded
2019
Website
bighatbio.com

Weighing a BigHat Biosciences offer?

Upload the offer letter to see what the equity is approximately worth at today's estimated price. No account needed.

X-ray an offer

Leaving BigHat Biosciences? Mind the window.

If you hold options, leaving usually starts a post-termination exercise clock, often 90 days. Miss it and vested options can expire worthless; exercise blindly and you may owe real money (including possible AMT) on shares you can't yet sell. Neither panic nor autopilot is a plan. Knowing your window, your exercise cost, and the current estimated price is.

Track my window freeUpload your grant doc. We extract the window and set the reminders.

BigHat Biosciences equity, answered plainly

Is BigHat Biosciences a public company?

No. BigHat Biosciences is privately held, which is exactly why its share price doesn't show up in your brokerage app. Its shares still change hands between eligible buyers and sellers on the secondary market, producing an observable estimated price.

What is BigHat Biosciences's stock price?

BigHat Biosciences has an observed estimated share price from secondary-market activity, updated as new data is observed. ExitCue members see the current estimate and its full history free, along with what their own grants are approximately worth at that price.

Can you sell BigHat Biosciences stock before an IPO?

Sometimes. Private-share sales depend on BigHat Biosciences's transfer restrictions, rights of first refusal, and whether the company runs tender offers or permits secondary sales. Your grant documents and the company's policies govern, but "hard to sell today" is not the same as "worth zero."

What happens to my BigHat Biosciences options if I leave?

Most option grants have a post-termination exercise window, commonly 90 days, sometimes longer, after which unexercised options expire worthless. The exact terms are in your grant documents. ExitCue reads those documents, tracks the deadline, and reminds you before the window closes.

How much is my BigHat Biosciences equity worth?

Multiply what you hold by the estimated share price, separating vested from unvested, and netting out strike prices for options. That's precisely the arithmetic ExitCue does for you, continuously, at the current observed estimate. It's an educational estimate, not a guarantee, and a far better anchor than the $0 the internet suggests.

What's the difference between BigHat Biosciences's 409A valuation and what its shares trade at?

The 409A is a tax-compliance appraisal, usually conservative, used to set option strike prices. Secondary-market pricing reflects what buyers and sellers actually agree to. The two frequently differ, which is why evaluating an offer on the 409A alone undersells (or oversells) it.

When will BigHat Biosciences IPO?

Unless BigHat Biosciences has publicly announced a listing, nobody knows, including the people who sound confident on forums. The practical upside of secondary markets is that you don't have to wait for an IPO to know approximately what the shares trade at.

Do my unvested BigHat Biosciences RSUs count for anything?

Unvested equity isn't yours yet, but it has an estimable value and a schedule. Seeing vested and unvested value separately, in dollars at the current estimated price, turns "some RSUs" into a number you can plan around.

General educational information, not advice about your specific situation. Grant terms vary; your documents govern.

Other private companies with observed prices